Department of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK
Mini Review
Targeting the PI3K/Akt/mTOR Signaling Pathway in Colorectal Cancer Treatment: Current Insights and Future Perspectives
Author(s): Johannes Christian*
Colorectal Cancer (CRC) remains a significant global health burden, necessitating the development of novel therapeutic strategies. The PI3K/Akt/
mTOR signaling pathway has emerged as a promising target in CRC due to its pivotal role in regulating cell proliferation, survival, and metabolism.
This article provides a comprehensive overview of the dysregulation of the PI3K/Akt/mTOR pathway in CRC and discusses the therapeutic
potential of targeting this pathway for CRC treatment. We explore the preclinical and clinical evidence supporting the efficacy of PI3K/Akt/mTOR
inhibitors in CRC, highlighting ongoing challenges and future directions in harnessing this pathway for improved patient outcomes... Read More»
DOI:
10.37421/2471-2671.2024.10.86
Archives of Surgical Oncology received 37 citations as per Google Scholar report